TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
HN1996000101A
(es)
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
HUP0000838A3
(en)
|
1997-04-15 |
2001-04-28 |
Csir |
Extract containing steroid-glucosid, process for its isolation and synthesis, pharmaceutical composition containing it having appetite suppressant activity
|
GB2324726A
(en)
*
|
1997-05-01 |
1998-11-04 |
Merck & Co Inc |
Combination Therapy for the Treatment of Osteoporosis
|
UA53716C2
(uk)
|
1997-06-25 |
2003-02-17 |
Пфайзер Продактс Інк. |
Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
|
AU7445498A
(en)
|
1997-06-25 |
1999-01-04 |
Pfizer Inc. |
Dipeptide derivatives as growth hormone secretagogues
|
UA64751C2
(uk)
|
1997-06-25 |
2004-03-15 |
Пфайзер Продактс Інк. |
Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
|
ZA987383B
(en)
*
|
1997-08-19 |
2000-02-17 |
Lilly Co Eli |
Treatment of congestive heart failure with growth hormone secretagogues.
|
US6329342B1
(en)
|
1997-08-19 |
2001-12-11 |
Eli Lilly And Company |
Treatment of congestive heart failure with growth hormone secretagogues
|
US6893877B2
(en)
|
1998-01-12 |
2005-05-17 |
Massachusetts Institute Of Technology |
Methods for screening substances in a microwell array
|
DE69921611T2
(de)
|
1998-01-16 |
2005-11-03 |
Novo Nordisk A/S |
Verbindungen mit wachstumshormon-freisetzenden eigenschaften
|
US6657063B1
(en)
*
|
1998-04-30 |
2003-12-02 |
Pfizer Inc. |
Combinations of β3 agonists and growth hormone secretagogues
|
DE69923448T2
(de)
*
|
1998-06-03 |
2005-12-29 |
Pfizer Products Inc., Groton |
2-aminopyridine mit kondensierten ringsubstituenten als stickstoff-oxid-synthase inhibitoren
|
PA8475901A1
(es)
*
|
1998-06-16 |
2000-05-24 |
Pfizer Prod Inc |
Terapia de combinacion para la fragilidad musculoesqueletica
|
PA8471201A1
(es)
*
|
1998-06-16 |
2000-09-29 |
Pfizer Prod Inc |
Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
|
IL139587A0
(en)
*
|
1998-06-16 |
2002-02-10 |
Pfizer Prod Inc |
Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty
|
US6639076B1
(en)
|
1998-08-18 |
2003-10-28 |
Eli Lilly And Company |
Growth hormone secretagogues
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
JP2002525274A
(ja)
*
|
1998-09-02 |
2002-08-13 |
メルク エンド カムパニー インコーポレーテッド |
成長ホルモン分泌促進剤による独立生活状況への復帰促進
|
CA2350638C
(en)
|
1998-09-11 |
2009-11-24 |
Gerhard Schmidmaier |
Biologically active implants coated with a biodegradable polymer
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
US6380184B1
(en)
|
1998-10-28 |
2002-04-30 |
Bristol-Myers Squibb Co. |
Benzoazepines and analogs thereof useful as growth hormone secretagogues
|
US6194578B1
(en)
*
|
1998-11-20 |
2001-02-27 |
Pfizer Inc. |
Dipeptide derivatives
|
SI1004583T1
(en)
*
|
1998-11-23 |
2004-12-31 |
Pfizer Products Inc. |
Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
|
US6297380B1
(en)
|
1998-11-23 |
2001-10-02 |
Pfizer Inc. |
Process and intermediates for growth hormone secretagogues
|
AU759022B2
(en)
|
1999-02-18 |
2003-04-03 |
Kaken Pharmaceutical Co., Ltd. |
Novel amide derivatives as growth hormone secretagogues
|
US6828331B1
(en)
|
1999-02-19 |
2004-12-07 |
Eli Lilly And Company |
Growth hormone secretagogues
|
US6541634B2
(en)
*
|
1999-02-26 |
2003-04-01 |
Pfizer Inc. |
Process for preparing growth hormone secretagogues
|
US6518292B1
(en)
|
1999-03-12 |
2003-02-11 |
Bristol-Myers Squibb Co. |
Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
|
US6525203B1
(en)
|
1999-03-12 |
2003-02-25 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
DE60023906T2
(de)
*
|
1999-07-26 |
2006-07-20 |
Baylor College Of Medicine, Houston |
Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
|
GB2355657B
(en)
|
1999-10-27 |
2004-07-28 |
Phytopharm Plc |
Inhibitors Of Gastric Acid Secretion
|
EP1113007A1
(en)
*
|
1999-12-24 |
2001-07-04 |
Pfizer Inc. |
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
|
DE60022683D1
(de)
*
|
1999-12-28 |
2005-10-20 |
Kaken Pharma Co Ltd |
Nervenschutzmittel
|
AU2001238606A1
(en)
*
|
2000-02-18 |
2001-08-27 |
Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and methods for parallel processing of micro-volume liquid reactions
|
US20020151040A1
(en)
*
|
2000-02-18 |
2002-10-17 |
Matthew O' Keefe |
Apparatus and methods for parallel processing of microvolume liquid reactions
|
EP1132388A3
(en)
*
|
2000-03-09 |
2004-03-03 |
Pfizer Products Inc. |
Hexahydropyrazolo[4,3-c]pyridine metabolites
|
EP1149583A3
(en)
*
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
|
ATE310728T1
(de)
|
2000-05-11 |
2005-12-15 |
Bristol Myers Squibb Co |
Tetrahydroisochinolin-analoga als wachstumshormon-sekretagoga
|
DOP2001000154A
(es)
*
|
2000-05-25 |
2002-05-15 |
Pfizer Prod Inc |
Combinación de secretagogos de hormona del crecimiento y antidepresivos
|
AU6497701A
(en)
|
2000-05-30 |
2001-12-11 |
Merck & Co Inc |
Melanocortin receptor agonists
|
EP1159964B1
(en)
*
|
2000-05-31 |
2009-10-28 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating gastrointestinal motility
|
IL143690A0
(en)
*
|
2000-06-19 |
2002-04-21 |
Pfizer Prod Inc |
The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
|
IL143942A0
(en)
*
|
2000-06-29 |
2002-04-21 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for treatment of physical performance decline
|
EP1181933A3
(en)
*
|
2000-06-29 |
2002-04-10 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating or increasing appetite
|
GB2363985B
(en)
|
2000-06-30 |
2004-09-29 |
Phytopharm Plc |
Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
|
IL144468A0
(en)
*
|
2000-07-27 |
2002-05-23 |
Pfizer Prod Inc |
Use of growth hormone secretagogues for improvement of functional health status
|
IL145106A0
(en)
*
|
2000-08-30 |
2002-06-30 |
Pfizer Prod Inc |
Intermittent administration of a geowth hormone secretagogue
|
BR0113626A
(pt)
|
2000-08-30 |
2003-06-17 |
Pfizer Prod Inc |
Formulações de liberação sustentada para secretores de hormÈnio do crescimento
|
EP1192943A3
(en)
*
|
2000-09-28 |
2002-11-27 |
Pfizer Products Inc. |
Use of growth hormone secretagogues in conjunction with physical exercise
|
US20100261159A1
(en)
|
2000-10-10 |
2010-10-14 |
Robert Hess |
Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
|
WO2002030561A2
(en)
*
|
2000-10-10 |
2002-04-18 |
Biotrove, Inc. |
Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
|
CA2372450A1
(en)
*
|
2001-05-10 |
2001-09-19 |
Pharmaceutical Partners Of Canada Inc. |
Liquid injectable formulation of disodium pamidronate
|
US7125840B2
(en)
|
2001-10-09 |
2006-10-24 |
Eli Lilly And Company |
Substituted dipeptides as growth hormone secretagogues
|
AU2002357692A1
(en)
|
2001-11-09 |
2003-05-26 |
Bristol-Myers Squibb Company |
Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
|
US20030199514A1
(en)
*
|
2002-03-27 |
2003-10-23 |
Fryburg David A. |
Methods for improving efficacy of treatment with growth hormone secretagogues
|
US7396846B2
(en)
|
2002-04-09 |
2008-07-08 |
Eli Lilly And Company |
Growth hormone secretagogues
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
US8277753B2
(en)
*
|
2002-08-23 |
2012-10-02 |
Life Technologies Corporation |
Microfluidic transfer pin
|
JP2006504694A
(ja)
*
|
2002-09-18 |
2006-02-09 |
サントル・オスピタリエ・ドゥ・リュニヴェルシテ・ドゥ・モントリオール・(シー・エイチ・ユー・エム) |
Ghrh類似体
|
US20060094108A1
(en)
*
|
2002-12-20 |
2006-05-04 |
Karl Yoder |
Thermal cycler for microfluidic array assays
|
AU2003302264A1
(en)
*
|
2002-12-20 |
2004-09-09 |
Biotrove, Inc. |
Assay apparatus and method using microfluidic arrays
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004108120A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for treatment of fibromyalgia
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
CN1902177A
(zh)
|
2003-09-22 |
2007-01-24 |
万有制药株式会社 |
新哌啶衍生物
|
US7129561B2
(en)
*
|
2003-11-19 |
2006-10-31 |
International Business Machines Corporation |
Tri-metal and dual-metal stacked inductors
|
JP2007529015A
(ja)
|
2004-03-12 |
2007-10-18 |
バイオトローブ, インコーポレイテッド |
ナノリットルのアレイローディング
|
EP1789409A4
(en)
*
|
2004-04-02 |
2010-09-08 |
Elixir Pharmaceuticals Inc |
SULPHONAMIDES AND ITS USES
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
WO2005097174A2
(en)
*
|
2004-04-07 |
2005-10-20 |
Gastrotech Pharma A/S |
Uses of a combination of ghrelin and somatotropin for the treatment of cachexia
|
PE20060574A1
(es)
|
2004-07-28 |
2006-06-24 |
Glaxo Group Ltd |
Derivados de arilpiperazina sulfonamida como agonistas de los receptores de secretagogos de la hormona del crecimiento (ghs)
|
US12070731B2
(en)
|
2004-08-04 |
2024-08-27 |
Life Technologies Corporation |
Methods and systems for aligning dispensing arrays with microfluidic sample arrays
|
US20060105453A1
(en)
*
|
2004-09-09 |
2006-05-18 |
Brenan Colin J |
Coating process for microfluidic sample arrays
|
US20070191283A1
(en)
*
|
2004-08-12 |
2007-08-16 |
Rejuvenon Corporation |
Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
|
JP2008510706A
(ja)
|
2004-08-18 |
2008-04-10 |
エリクシアー ファーマシューティカルズ, インコーポレイテッド |
成長ホルモン分泌促進物質
|
RU2417985C2
(ru)
|
2005-05-30 |
2011-05-10 |
Баниу Фармасьютикал Ко., Лтд. |
Новые производные пиперидина
|
CA2618112A1
(en)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone compound
|
AU2006282260A1
(en)
|
2005-08-24 |
2007-03-01 |
Msd K.K. |
Phenylpyridone derivative
|
EP1939194A4
(en)
|
2005-09-07 |
2010-12-08 |
Banyu Pharma Co Ltd |
AROMATIC SUBSTITUTED BICYLIC PYRIDONE DERIVATIVE
|
BRPI0616463A2
(pt)
|
2005-09-29 |
2011-06-21 |
Merck & Co Inc |
composto, composição farmacêutica, e, uso de um composto
|
WO2007048027A2
(en)
|
2005-10-21 |
2007-04-26 |
Novartis Ag |
Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
NZ568292A
(en)
|
2005-11-10 |
2011-08-26 |
Msd Kk |
Spiro[cyclohexane-1,1'-(3'H)-4'-azaisobenzofuran]-4-carboxamide derivatives
|
BRPI0618824A2
(pt)
*
|
2005-11-21 |
2011-09-13 |
Univ Miyazaki |
agente terapêutico acelerador de recuperação dérmica contendo grelina e derivados desta ou substáncias que atuam sobre ghs-r1a como ingrediente ativo
|
US8273702B2
(en)
*
|
2006-02-17 |
2012-09-25 |
Wake Forest University Health Sciences |
Wound healing compositions containing keratin biomaterials
|
CU23592A1
(es)
*
|
2006-02-28 |
2010-11-11 |
Ct Ingenieria Genetica Biotech |
Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
US20100227806A1
(en)
*
|
2006-03-10 |
2010-09-09 |
Tulipano Giovanni |
Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment
|
WO2008028688A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Bayer Schering Pharma Aktiengesellschaft |
Compounds and methods for 18f labeled agents
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
JPWO2008038692A1
(ja)
|
2006-09-28 |
2010-01-28 |
萬有製薬株式会社 |
ジアリールケチミン誘導体
|
KR20090085599A
(ko)
*
|
2006-10-02 |
2009-08-07 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
Pet 영상화용 규소 유도체
|
US20080114055A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Zoltan Laboratories Llc |
Thioxanthone Compounds to Reverse Weight Loss
|
EA200901077A1
(ru)
|
2007-02-09 |
2010-04-30 |
Транзим Фарма, Инк. |
Макроциклические модуляторы грелинового рецептора и их применение
|
MX2009009291A
(es)
*
|
2007-03-01 |
2009-12-14 |
Bayer Schering Pharma Ag |
Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo.
|
US8877717B2
(en)
|
2007-03-12 |
2014-11-04 |
Zadec Aps |
Anti-diabetic extract of rooibos
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
CA2682727C
(en)
|
2007-04-02 |
2016-03-22 |
Banyu Pharmaceutical Co., Ltd. |
Indoledione derivative
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
WO2008151512A1
(en)
*
|
2007-06-12 |
2008-12-18 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Site-specific pegylated linear salmon calcitonin derivatives
|
CA2714617A1
(en)
|
2008-03-06 |
2009-09-11 |
Banyu Pharmaceutical Co., Ltd. |
Alkylaminopyridine derivative
|
US20110015198A1
(en)
|
2008-03-28 |
2011-01-20 |
Banyu Pharmaceutical Co., Inc. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
EP2301936A1
(en)
|
2008-06-19 |
2011-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
WO2010009319A2
(en)
|
2008-07-16 |
2010-01-21 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
EP2319841A1
(en)
|
2008-07-30 |
2011-05-11 |
Msd K.K. |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2166009A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as nadph oxidase inhibitors
|
CA2741125A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
EP2350010B1
(en)
|
2008-10-30 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
CN102271509A
(zh)
|
2008-10-31 |
2011-12-07 |
默沙东公司 |
用于抗糖尿病药的新型环苯并咪唑衍生物
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
EP2361912A1
(en)
|
2010-02-18 |
2011-08-31 |
GenKyoTex SA |
Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
|
EP2361911A1
(en)
*
|
2010-02-18 |
2011-08-31 |
GenKyoTex SA |
Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
EP2540721B1
(en)
*
|
2010-02-26 |
2016-12-14 |
RaQualia Pharma Inc. |
Ghrelin receptor agonist for treatment of cachexia
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
EP2677869B1
(en)
|
2011-02-25 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
JP6113144B2
(ja)
*
|
2011-04-21 |
2017-04-12 |
セラテクノロジーズ・インコーポレーテッド |
成長ホルモン放出因子(grf)類似体およびその使用
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
EP2854810A4
(en)
*
|
2012-05-25 |
2016-04-06 |
Raqualia Pharma Inc |
GHRELIN RECEPTOR AGONISTS FOR THE TREATMENT OF ACHLORHYDRIA
|
CA2880901A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
PL3524260T3
(pl)
|
2012-09-27 |
2023-11-27 |
Elanco Animal Health Incorporated |
Kompozycje farmaceutyczne do leczenia braku apetytu
|
US20150265680A1
(en)
|
2012-10-24 |
2015-09-24 |
Daiichi Sankyo Company, Limited |
Therapeutic agent for amyotrophic lateral sclerosis
|
WO2014130608A1
(en)
|
2013-02-22 |
2014-08-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
WO2014192294A1
(en)
*
|
2013-05-28 |
2014-12-04 |
Raqualia Pharma Inc. |
Polymorph forms
|
JP6606491B2
(ja)
|
2013-06-05 |
2019-11-13 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
|
KR102051433B1
(ko)
*
|
2013-08-27 |
2020-01-08 |
(주)네오팜 |
근육 분화 촉진 및 근육 강화용 조성물 및 외용제
|
US9119832B2
(en)
|
2014-02-05 |
2015-09-01 |
The Regents Of The University Of California |
Methods of treating mild brain injury
|
WO2016021191A1
(en)
*
|
2014-08-05 |
2016-02-11 |
Raqualia Pharma Inc. |
Serine derivatives as ghrelin receptor agonists
|
DK3186242T3
(da)
|
2014-08-29 |
2021-12-20 |
Tes Pharma S R L |
Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
|
CN106795158A
(zh)
*
|
2014-10-31 |
2017-05-31 |
拉夸里亚创药株式会社 |
作为生长激素释放肽受体激动剂的四氢吡唑并吡啶衍生物
|
US20170121385A1
(en)
|
2015-10-28 |
2017-05-04 |
Oxeia Biopharmaceuticals, Inc. |
Methods of treating neurodegenerative conditions
|
AR109950A1
(es)
|
2016-10-14 |
2019-02-06 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
CN109320515A
(zh)
*
|
2018-11-22 |
2019-02-12 |
常州大学 |
一种Capromorelin手性中间体的不对称合成方法
|
US11098029B2
(en)
|
2019-02-13 |
2021-08-24 |
Merck Sharp & Dohme Corp. |
5-alkyl pyrrolidine orexin receptor agonists
|